venBio Select Advisor »

Soleno Therapeutics shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2023-12-31 $32M 785k 40.25

More positions owned by venBio Select Advisor

Apellis Pharmaceuticals Common (APLS)
United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Argenx Se Sponsored ADR (ARGX)
Madrigal Pharmaceuticals Common (MDGL)
Sarepta Therapeutics Common (SRPT)
Biomarin Pharmaceutical Common (BMRN)
Spdr Series Trust - S&p Biotech Etf (XBI)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Krystal Biotech Common (KRYS)
Mirati Therapeutics Common
Cymabay Therapeutics Common
Xenon Pharmaceuticals Common (XENE)
Alnylam Pharmaceuticals Common (ALNY)

View all positions for venBio Select Advisor

Top funds holding Soleno Therapeutics

Vivo Capital
Perceptive Advisors
Carlyle
Nantahala Capital Management
Henderson Group
Vanguard Group
Balyasny Asset Management
venBio Select Advisor
Commodore Capital
Ikarian Capital
Frazier Life Sciences Management
Samlyn Capital
Emerald Advisers
Wellington Management Company
Emerald Mutual Fund Advisers, Trust

View all funds holding Soleno Therapeutics